GoingToMeet

The New Developments in Breast Cancer symposium will address critical issues concerning decision making for and treatment of patients with breast cancer, with an emphasis on new data presented at recent major international oncology meetings. The goal of this symposium is to update oncologists on the latest data in a format that allows them to apply the information to the optimal care of patients. Controversial and emerging topics will be addressed, including specific adjuvant and neoadjuvant therapies for defined clinical situations, the evolving role of HER2-targeted agents in the treatment of both early-stage and advanced/metastatic breast cancer, and emerging biologic and cytotoxic agents under evaluation for the treatment of metastatic breast cancer. In addition, novel diagnostic and predictive tools for the assessment of risk and optimization of therapy will be reviewed. New strategies and novel agents under investigation for the management of treatment-related adverse events will also be discussed. Case presentations and panel discussions will allow participants to discuss current controversies in the treatment of breast cancer with the faculty.